Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a caucasian male population

Hypertension Research

Volumn 31, Issue 6, 2008, Pages 1093-1100

  Masuo, Kazuko ^a   Straznicky, Nora E ^a   Lambert, Gavin W ^a   Katsuya, Tomohiro ^b   Sugimoto, Ken ^b   Rakugi, Hiromi ^b   Socratous, Florentia ^a   Hastings, Jacqueline ^a   Lambert, Elisabeth A ^a   Ogihara, Toshio ^b   Esler, Murray D ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hypertension; Leptin receptor polymorphisms; Obesity; Plasma leptin levels; Sympathetic nerve activity

Indexed keywords

ARGININE; ASPARAGINE; GLYCINE; LEPTIN; LEPTIN RECEPTOR; LYSINE; NORADRENALIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SUPINE POSITION; SYMPATHETIC NERVE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ALLELES; BLOOD PRESSURE; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, LEPTIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 48349132166     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1093     Document Type: Article

References (42)

1. Considine RV, Sinha MK, Heiman ML, et al: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
2. Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck ML: β2- and β3-Adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005; 111: 3429-3434.
3. Rosmond R, Chagnon YC, Holm G, et al: Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab 2000; 85: 3126-3131.
4. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409-414.
5. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of leptin in fat reguladon. Nature 1996; 380: 677.
6. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, et al: Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997; 100: 2858-2864.
7. Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG: Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes 2005; 54: 2012-2018.
8. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor-mediated regional sympathetic: nerve activation by leptin. J Clin Invest 1997; 100: 270-278.
9. Masuo K, Katsuya T, Kawaguchi H, et al: Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. Am J Hypertens 2006; 19: 1084-1089.
10. Arner P: Genetic variance and lipolysis regulation: implications for obesity. Ann Med 2001; 33: 542-546.
11. Wauters M, Considine RV, Chagnon M, et al: Leptin levels, leptin receptor gene polymorphisms, and energy metabolism in women. Obes Res 2002; 10: 394-400.
12. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klimis-Zacas D, Mantzoros S: The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 2001;86:4434-4439.
13. Portoles O, Sorli JV, Frances F, et al: Effect of genetic variation in the leptin gene promoter and the leptin receptor gene on obesity risk in a population-based case-controll study in Spain. Eur J Epidemiol 2006; 21: 605-612.
14. Chagnon YC, Wilmore JH, Borecki IB, et al: Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab 2000; 85: 29-34.
15. Guizar-Mendoza JM, Amador-Licona N, Flores-Martines SE, López-Cardona MG, Ahuatzin-Trémary R, Sánchez-Corona J: Association analysis of the Gln223Arg polymorphism in the human leptin receptor gene, and traits related to obesity in Mexican adolescents. J Hum Hypertens 2005; 19: 341-346.
16. Kuczmarski RJ, Ogden CL, Grummer-Straun LM, et al: CDC growth charts: United States. Adv Data 2000; 314: 1-27.
17. Masuo K, Mikami H, Ogihara T, Tuck ML: Weight reduction and pharmacological treatment in obesity hypertensives. Am J Hypertens 2001; 14: 530-538.
18. Masuo K, Mikami H, Ogihara T, Tuck ML: Weight gain-induced blood pressure elevation. Hypertension 2000; 35: 1135-1140.
19. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-480.
20. Esler M, Jackman G, Bobik A, et al: Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 1979; 25: 1461-1470.
21. Straznicky N, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ: Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90: 5998-6005.
22. Campfield LA, Smith FJ, Burn P: The OB protein (leptin) pathway - a link between adipose tissue mass and central neural networks. Horm Metab Res 1996; 28: 619-632.
23. Tartaglia LA, Dembski M, Weng X, et al: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-1271.
24. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-769.
25. Magni P, Vettor R, Pagano C, et al: Expression of leptin receptor in immortalized gonadotropin-releasing hormone-secreting neurons. Endocrinology 1999; 140: 1581-1585.
26. Considine RV, Considine EL, Williams CJ, Hyde TM, Caro JF: The hypothalamic leptin receptors in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996; 45; 992-994.
27. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Deuton DA, Friedman JM, Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A 1997; 94: 8878-8883.
28. Polleymounter MA, Cullen MJ, Baker MB, et al: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
29. Polleymounter MA, Cullen MJ, Healy D, Hecht R, Winteers D, McCaleb M: Efficancy of exogeneous recombinant murine leptin in lean and obese 10- to 12-mo-old female SD-1 mice. Am J Physiol 1998; 275: R950-R959.
30. Hukshorn CJ, Westerterp-Plantenga MS, Saris WHM: Pegylated human recombinant leptin (PEG-OB) causes additional weight loss in severely energy-restricted, over-weight man. Am J Clin Nutr 2003; 77: 771-776.
31. Hukshorn CJ, Saris WHM, Westerterp-Plantenga MS, Farid AR, Smith FJ, Campfield LA: Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab 2000; 85: 4003-4009.
32. Considine RV: Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions. Semin Vas Med 2005; 5: 15-24.
33. Chagnon YC, Perusse L, Lamothe M, et al: Suggestive linkage between markers on human 1p32-p22 and body fat and insulin levels in the Quebec Family Study. Obes Res 1997; 5: 115-121.
34. Zacharova J, Chiasson JL, Laakso M: Leptin receptor gene variation predicts weight-change in subjects with impaired glucose tolerance. Obes Res 2005; 13: 501-506.
35. Mars M, van Rossum CT, de Graaf C, Hoebee B, de Groot LC, Kok FJ: Leptin responsiveness to energy restriction: genetic variation in the leptin receptor gene. Obes Res 2004; 12: 442-444.
36. Paracchini V, Pedotti P, Taioli E: Genetics of leptin and obesity: a HuGE review. Am J Epidemiol 2006; 162: 101-114.
37. Norman RA, Leibel RL, Chung WK, et al: Absence of linkage of obesity and energy metabolism to markers flunking homologues of rodent obesity genes in Pima Indians. Diabetes 1996; 45: 1229-1232.
38. Francke S, Clement K, Dina C, et al: Genetic studies of the leptin receptor gene in morbidly obese French Caucasian families. Hum Genet 1997; 100: 491-496.
39. Chagnon YC, Chung WK, Perusse L, Chagnon M, Leibel RL, Bouchard C: Linkage and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int J Obes 1999; 23: 278-286.
40. Kawaguchi H, Masuo K, Katsuya T, Sugimoto K, Rakugi H, Ogihara T, Tuck ML: β2- and β3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals. Hypertens Res 2006; 29: 951-959.
41. Correia ML, Morgan DA, Sivitz WI, Mark AL, Haynes WG: Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001; 37: 936-942.
42. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-1314.